About this episode
As part of a special two-week series featuring highlights from Julius Baer’s recent Beyond Markets podcasts, today's show features a clip from a conversation one of our Next Generation analysts, Damien Ng, had with host Emily Rookwood about the background and economic significance of obesity drugs. Our regular show that starts with daily market news returns on Monday 6th January. 00:00 Introduction by Helen Freer (Investment Writing) 00:38 What is the cost of obesity? Damien Ng (Next Generation Research), Emily Rookwood (Head of Publications) 06:05 Closing remarks by Helen Freer (Investment Writing) Would you like to support this show? Please leave us a review and star rating on Apple Podcasts, Spotify or wherever you get your podcasts.